GlassScriptPhysician profile
Jeffrey Olson
NPI 1356871594
$10,641.95
in general payments reported to CMS, 2019-2025
13 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $260 · 2021: $192 · 2022: $2,175 · 2023: $2,735 · 2024: $3,251 · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,391 · Food and Beverage: $3,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,391.09 |
| Food and Beverage | $3,296.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,808.30 | 2019-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Aequalis Perform Reversed |
| Medical Device Business Services, INC. | $1,839.98 | 2019-2023 | Dynacord |
| Encore Medical, LP | $1,566.39 | 2022 | |
| Shoulder Innovations, INC. | $1,550.20 | 2024 | Inset System |
| Arthrex, INC. | $1,104.70 | 2024 | |
| Depuy Synthes Sales INC. | $630.42 | 2022-2024 | Attune, Actis, Va-Lcp |
| Restor3d, INC. | $401.92 | 2025 | |
| Kairos Surgical INC | $267.80 | 2024 | |
| Medacta USA, INC. | $150.00 | 2025 | Primary Shoulder |
| Linvatec Corporation | $143.39 | 2024 | Biobrace 23mm |
| Innovation Technologies INC | $81.68 | 2023 | Irrisept |
| Elite Orthopedics, LLC | $64.17 | 2022-2023 | |
| Zimmer Biomet Holdings, INC. | $33.00 | 2023 | Mymobility Platform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.